Company Overview and News

1
GoPro's stock surges after Oppenheimer says it is time to buy

5m marketwatch
Shares of GoPro Inc. GPRO, +3.92% shot up 5% in premarket trade Wednesday, after Oppenheimer analyst Andrew Uerkwitz turned bullish on the action camera maker, citing optimism surrounding new product launches and a new focused strategy. Uerkwitz raised his rating to outperform from perform, and issued a stock price target of $9, which is 36% above Tuesday's closing price of $6.62, and would be the highest price seen since November 2017.
GPRO

1
Gopro Transformation To Consumer Camera Company Complete

18h seekingalpha
GoPro (GPRO) released the Hero 7 cameras on September 20. Yes, cameras plural. I have written quite a bit about GoPro product development issues. GoPro has been releasing products that were not ready, not tested and badly thought out. A note written on a black board in a development lab I worked said, “Stick to your knitting!!!” After three years of product releases bringing GoPro close to disaster they read the message.
GPRO

16
GoPro Stock Shows a Short-Term Glimmer of Hope With New Camera Intros

22h investorplace
Action camera company GoPro (NASDAQ:GPRO) unveiled its lineup of new products on Thursday, launching just ahead of this year’s all-important holiday shopping season. GoPro stock rallied a bit because, well, at least a small faction of investors rev up their bullishness whenever the company makes any sort of move.
GPRO FB FIT SNAP

53
The Smartest Move Is to Sell Roku Stock Before the Correction Comes

2018-09-25 investorplace - 1
Roku (NASDAQ:ROKU) has been on a winning streak this summer. In just a few months, ROKU stock is up more than 50%. Previously, Roku had seen more sideways trading as investors and analysts considered various pros and cons affecting the company.
SONO GPRO FIT AMZN ROKU NFLX DIS

28
Can We Finally Call Snap Stock a Lost Cause?

2018-09-23 investorplace - 1
The story sounded like a good one at the time. Snap (NYSE:SNAP), the parent company of messaging platform Snapchat, was following in the footsteps of highly successful social networking companies like Facebook (NASDAQ:FB) and Twitter (NYSE:TWTR). Surely SNAP stock would be a winner, too.
GPRO GRPN FB GOOGL TWTR GOOG SNAP

5
Dinner And A Movie Gone Wrong - The Idea Guide

2018-09-21 seekingalpha - 2
This week's selected long ideas range from a semiconductor giant with an attractive cyclical position to a trust with potential hidden value.
GPRO OPK SSNLF WLL GLNG DOMR WHZT WHZ INTC

1
GoPro stock gains after company announces new Hero7 camera line

2018-09-20 marketwatch
Shares of GoPro Inc. GPRO, +1.58% are up 2% in Thursday morning trading after the company announced its new Hero7 family of cameras. The Hero7 Black camera, which goes for $399, has what the company calls "the best in-camera video stabilization ever featured in a camera" as well as live-streaming abilities. The company also announced its new $299 Hero7 Silver and $199 Hero7 White cameras, which are waterproof to 33 feet and support voice commands.
GPRO

1
GoPro Kolor Closes

2018-09-17 seekingalpha
The GoPro (NASDAQ:GPRO) spiral continues. Kolor website posted a statement on its website that as of September 14, 2018 Kolor products will no longer be for sale from Kolor.
GPRO

94
15 Digital Ad Stocks to Buy for the Long Run

2018-09-12 investorplace
These were once a group of the market’s highest flyers, as a mass exodus of advertising dollars from traditional channels to digital channels caused digital advertiser’s revenues, profits and stock prices to shoot higher.
FB FIT PYPL NFLX GOOG GPRO MTCH BABA AMZN SPOT GOOGL TWTR ROKU VZ MSFT BIDU TTD SNAP

43
Why Sonos Stock Looks Like the Next GoPro or Fitbit

2018-09-12 investorplace - 1
Some companies don’t get it right the first time. Wireless and home speaker manufacturer Sonos (NASDAQ:SONO) just reported its first quarterly numbers as a public company. They didn’t live up to expectations. Sonos stock dropped.
SONO GPRO FB FIT AMZN GOOGL ROKU AAPL GOOG

23
4 Reasonably-Priced Wearables Stocks to Strap On Today

2018-09-11 investorplace
The rise and fall of Fitbit (NYSE:FIT) and GoPro (NASDAQ:GPRO) has made many investors wary of wearables stocks. Indeed, when one takes more of a macro perspective, some of these names can look like no-moat companies who take a sensor and linking it to an app.
HMI GPRO FIT NKE GOOGL GRMN AAPL GOOG FOSL

2
3 Up-and-Coming Startups to Watch

2018-09-07 investorplace
Many investors, unless they’re venture capitalists, tend to think of startups as something that exist in a different land. While it’s fun to hear about innovation and possibilities, the average investor isn’t afforded many opportunities to put their money into a startup. The main options are crowdfunding platforms or a handful of ETFs that target new kids on the block. So it’s hard to know which startups to watch.
GPRO MSFT CRM

1
GoPro. (GPRO) CEO Nick Woodman Presents at Citi 2018 Global Technology Conference (Transcript)

2018-09-06 seekingalpha
Good morning. My name is Josh Kehoe. On behalf of Jim Suva, Citi's IT Hardware, Electronic Manufacturing Services and Telecom Equipment and Networking Analyst. I would like to welcome you all to Citi's 2018 Global Tech Conference Day 2.
GPRO

7
Risks Are Still High for Investors in Ambarella Stock

2018-09-05 investorplace
After Ambarella (NASDAQ:AMBA) posted quarterly results, the stock tanked by around $5 at the open. The weak near-term outlook and the quarterly loss of $0.21 a share should concern investors. Despite the promise of CV, or computer vision, Ambarella is still a “show me” company.
GPRO AMBA NVDA INTC

3
Turn This Dip Into Profits in Ambarella Stock

2018-09-04 investorplace
A forecast-induced near-wipeout in Ambarella (NASDAQ:AMBA) following earnings may be setting up a sunnier long-term outlook. But if you’re looking for a more stable ride in AMBA stock, a bullish combined spread position with limited and reduced risk is one to consider. Let me explain.
GPRO AMBA

GPRO: GoPro Analysis and Research Report

2018-08-23 - Asif

Overview GoPro is enabling the way people capture and share their lives from a perspective only achieved with a GoPro. What began as an idea to help athletes document themselves engaged in sport, GoPro has become a mobile storytelling solution that helps the world share itself through immersive content. Helping people capture, share experiences and manage content is at the core of its business. GoPro is committed to developing solutions that create an easy, seamless experience for consumers to capture, create, enjoy and store engaging personal content. When consumers use its products and services, those products and services enable compelling, authentic content that organically increases awareness for GoPro, driving a virtuous cycle and a self-reinforcing demand for its products. The company believe revenue growth may be driven by the introduction of new cameras, offerings, accessories and software applications. The company believe new camera features and related services dr...

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

18h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

Silicon Investor Message Boards

This table lists all message boards related to GPRO / GoPro, Inc. on message board site Silicon Investor.

GoPro - Be A Hero GoPro - Be A Hero GoPro - Be A Hero
CUSIP: 38268T103